She runs a highly successful and productive laboratory and has a national reputation for stellar science in the field of translational research and local delivery of chemotherapeutic agents for brain tumor therapy. Betty assisted in the preclinical studies that led to bringing Gliadel to brain tumor patients as a standard of care, and currently the focus of Betty’s work and primary funding has been to develop and take a second locally delivered chemotherapeutic agent to clinical trials. Betty’s collaborative efforts with scientists within Johns Hopkins as well as with researchers throughout the United States have led to multiple scientific breakthroughs. In addition to publishing over 85 peer-reviewed articles she has mentored and taught over 250 neurosurgical residents, medical students, and undergraduate students in research design, surgical techniques and statistical analysis. Biography